R. Gupta, E. Springston, M. Warrier, B. Smith, R. Kumar et al., The Prevalence, Severity, and Distribution of Childhood Food Allergy in the United States, PEDIATRICS, vol.128, issue.1, 2011.
DOI : 10.1542/peds.2011-0204

L. Soller, M. Ben-shoshan, D. Harrington, J. Fragapane, L. Joseph et al., Overall prevalence of self-reported food allergy in Canada, J Allergy Clin Immunol, 2012.

D. Umetsu, R. Rachid, and L. Schneider, Oral immunotherapy and anti-IgE antibody treatment for food allergy, World Allergy Organization Journal, vol.25, issue.1, p.20, 2015.
DOI : 10.1186/s40413-015-0070-3

S. Sicherer and H. Sampson, Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment, Journal of Allergy and Clinical Immunology, vol.133, issue.2, pp.291-307, 2014.
DOI : 10.1016/j.jaci.2013.11.020

W. Liew, E. Williamson, and M. Tang, Anaphylaxis fatalities and admissions in Australia, Journal of Allergy and Clinical Immunology, vol.123, issue.2, pp.434-476, 2009.
DOI : 10.1016/j.jaci.2008.10.049

D. Moneret-vautrin, ??pid??miologie de l???allergie alimentaire, Revue Fran??aise d'Allergologie et d'Immunologie Clinique, vol.48, issue.3, pp.171-179, 2008.
DOI : 10.1016/j.allerg.2008.01.018

D. Patel, D. Holdford, E. Edwards, and N. Carroll, Estimating the economic burden of food-induced allergic reactions and anaphylaxis in the United States, Journal of Allergy and Clinical Immunology, vol.128, issue.1, 2011.
DOI : 10.1016/j.jaci.2011.03.013

O. Keefe, A. , D. Schryver, S. Mill, J. Mill et al., Diagnosis and management of food allergies: new and emerging options: a systematic review, J Asthma Allergy, vol.7, pp.141-64, 2014.

H. Ercan, A. Ozen, H. Karatepe, M. Berber, and R. Cengizlier, Primary school teachers' knowledge about and attitudes toward anaphylaxis. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol, pp.428-460, 2012.
DOI : 10.1111/j.1399-3038.2012.01307.x

M. Groetch and A. Nowak-wegrzyn, Practical approach to nutrition and dietary intervention in pediatric food allergy. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol, pp.212-233, 2013.
DOI : 10.1111/pai.12035

S. Flammarion, C. Santos, D. Guimber, L. Jouannic, C. Thumerelle et al., Diet and nutritional status of children with food allergies. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol, pp.161-166, 2011.

A. Diamanti, S. Pedicelli, D. Argenio, P. Panetta, F. Alterio et al., Iatrogenic Kwashiorkor in three infants on a diet of rice beverages. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol, pp.878-887, 2011.

O. Palomares, The role of regulatory T cells in IgE-mediated food allergy, J Investig Allergol Clin Immunol, vol.23, issue.6, pp.371-82, 2013.

J. Kong, Z. Zhang, M. Musch, G. Ning, J. Sun et al., Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier, AJP: Gastrointestinal and Liver Physiology, vol.294, issue.1, pp.208-224, 2007.
DOI : 10.1152/ajpgi.00398.2007

K. Allen, J. Koplin, A. Ponsonby, L. Gurrin, M. Wake et al., Vitamin D insufficiency is associated with challenge-proven food allergy in infants, Journal of Allergy and Clinical Immunology, vol.131, issue.4, 2013.
DOI : 10.1016/j.jaci.2013.01.017

A. Stefka, T. Feehley, P. Tripathi, J. Qiu, K. Mccoy et al., Commensal bacteria protect against food allergen sensitization, Proceedings of the National Academy of Sciences, vol.111, issue.36, pp.13145-50, 2009.
DOI : 10.1073/pnas.1412008111
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246970

J. Metsälä, A. Lundqvist, L. Virta, M. Kaila, M. Gissler et al., Mother's and Offspring's Use of Antibiotics and Infant Allergy to Cow's Milk: Epidemiology, pp.303-312, 2013.

T. Torgerson, A. Linane, N. Moes, S. Anover, V. Mateo et al., Severe Food Allergy as a Variant of IPEX Syndrome Caused by a Deletion in a Noncoding Region of the FOXP3 Gene, Gastroenterology, vol.132, issue.5, pp.1705-1722, 2007.
DOI : 10.1053/j.gastro.2007.02.044
URL : https://hal.archives-ouvertes.fr/hal-00152519

B. Schaub, J. Liu, S. Höppler, S. Haug, C. Sattler et al., Impairment of T-regulatory cells in cord blood of atopic mothers, Journal of Allergy and Clinical Immunology, vol.121, issue.6, pp.1491-1500, 2008.
DOI : 10.1016/j.jaci.2008.04.010

M. Karlsson, J. Rugtveit, and P. Brandtzaeg, Regulatory T Cells in Children who Have Outgrown Cow's Milk Allergy, The Journal of Experimental Medicine, vol.9, issue.12, pp.1679-88, 2004.
DOI : 10.1002/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212808

G. Sletten, R. Halvorsen, E. Egaas, and T. Halstensen, Memory T Cell Proliferation in Cow???s Milk Allergy after CD25+ Regulatory T Cell Removal Suggests a Role for Casein-Specific Cellular Immunity in IgE-Mediated but Not in Non-IgE-Mediated Cow???s Milk Allergy, International Archives of Allergy and Immunology, vol.142, issue.3, pp.190-198, 2007.
DOI : 10.1159/000097021

H. Fujita, M. Soyka, M. Akdis, and C. Akdis, Mechanisms of allergen-specific immunotherapy, Clinical and Translational Allergy, vol.2, issue.1, 2012.
DOI : 10.1186/2045-7022-2-2

C. Smarr, P. Bryce, and S. Miller, Antigen-Specific Tolerance in Immunotherapy of Th2-Associated Allergic Diseases, Critical Reviews in Immunology, vol.33, issue.5, pp.389-414, 2013.
DOI : 10.1615/CritRevImmunol.2013007046

A. Syed, M. Garcia, S. Lyu, R. Bucayu, A. Kohli et al., Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3), Journal of Allergy and Clinical Immunology, vol.133, issue.2, pp.500-510, 2014.
DOI : 10.1016/j.jaci.2013.12.1037

H. Yamashita, K. Takahashi, H. Tanaka, H. Nagai, and N. Inagaki, Overcoming food allergy through acquired tolerance conferred by transfer of Tregs in a murine model, Allergy, vol.123, issue.2, p.2012
DOI : 10.1111/j.1398-9995.2011.02742.x

B. Bonnet, J. Vigneron, B. Levacher, T. Vazquez, F. Pitoiset et al., Low-Dose IL-2 Induces Regulatory T Cell???Mediated Control of Experimental Food Allergy, The Journal of Immunology, vol.197, issue.1, 1950.
DOI : 10.4049/jimmunol.1501271

R. Kanjarawi, C. Dercamp, N. Etchart, K. Adel-patient, J. Nicolas et al., Regulatory T Cells Control Type I Food Allergy to Beta-Lactoglobulin in Mice, International Archives of Allergy and Immunology, vol.156, issue.4, pp.387-96, 2011.
DOI : 10.1159/000323940

E. Ling, T. Smith, X. Nguyen, C. Pridgeon, M. Dallman et al., Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease, The Lancet, vol.363, issue.9409, pp.608-623, 2004.
DOI : 10.1016/S0140-6736(04)15592-X

F. Cottrez, S. Hurst, R. Coffman, and H. Groux, T Regulatory Cells 1 Inhibit a Th2-Specific Response In Vivo, The Journal of Immunology, vol.165, issue.9, pp.4848-53, 1950.
DOI : 10.4049/jimmunol.165.9.4848

J. Satoguina, E. Weyand, J. Larbi, and A. Hoerauf, T Regulatory-1 Cells Induce IgG4 Production by B Cells: Role of IL-10, The Journal of Immunology, vol.174, issue.8, pp.4718-4744, 1950.
DOI : 10.4049/jimmunol.174.8.4718

F. Van-wijk, S. Nierkens, W. De-jong, E. Wehrens, L. Boon et al., The CD28/CTLA-4-B7 Signaling Pathway Is Involved in Both Allergic Sensitization and Tolerance Induction to Orally Administered Peanut Proteins, The Journal of Immunology, vol.178, issue.11, pp.6894-900, 1950.
DOI : 10.4049/jimmunol.178.11.6894

F. Meiler, S. Klunker, M. Zimmermann, C. Akdis, and M. Akdis, Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors, Allergy, vol.119, issue.11, pp.1455-63, 2008.
DOI : 10.1111/j.1398-9995.2008.01774.x

G. Gri, S. Piconese, B. Frossi, V. Manfroi, S. Merluzzi et al., CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity, pp.771-81, 2008.
DOI : 10.1016/j.immuni.2008.08.018
URL : http://doi.org/10.1016/j.immuni.2008.08.018

M. Kashyap, A. Thornton, S. Norton, B. Barnstein, M. Macey et al., Cutting Edge: CD4 T Cell-Mast Cell Interactions Alter IgE Receptor Expression and Signaling, The Journal of Immunology, vol.180, issue.4, pp.2039-2082, 1950.
DOI : 10.4049/jimmunol.180.4.2039

J. Rolland, L. Gardner, O. Hehir, and R. , Allergen-related approaches to immunotherapy, Pharmacology & Therapeutics, vol.121, issue.3, pp.273-84, 2009.
DOI : 10.1016/j.pharmthera.2008.11.007

L. Zuidmeer-jongejan, M. Fernandez-rivas, L. Poulsen, A. Neubauer, J. Asturias et al., FAST: towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies, Clinical and Translational Allergy, vol.2, issue.1, p.5, 2012.
DOI : 10.1016/j.jaci.2009.02.010

A. Burks, S. Jones, R. Wood, D. Fleischer, S. Sicherer et al., Oral Immunotherapy for Treatment of Egg Allergy in Children, New England Journal of Medicine, vol.367, issue.3, pp.233-276, 2012.
DOI : 10.1056/NEJMoa1200435

L. Caminiti, G. Pajno, G. Crisafulli, F. Chiera, M. Collura et al., Oral Immunotherapy for Egg Allergy: A Double-Blind Placebo-Controlled Study, with Postdesensitization Follow-Up, The Journal of Allergy and Clinical Immunology: In Practice, vol.3, issue.4, pp.532-541
DOI : 10.1016/j.jaip.2015.01.017

P. Varshney, S. Jones, A. Scurlock, T. Perry, A. Kemper et al., A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response, Journal of Allergy and Clinical Immunology, vol.127, issue.3, pp.654-60, 2011.
DOI : 10.1016/j.jaci.2010.12.1111

C. Keet, P. Frischmeyer-guerrerio, A. Thyagarajan, J. Schroeder, R. Hamilton et al., The safety and efficacy of sublingual and oral immunotherapy for milk allergy, Journal of Allergy and Clinical Immunology, vol.129, issue.2, pp.448-55, 2012.
DOI : 10.1016/j.jaci.2011.10.023

D. Chiang and M. Berin, An Examination of Clinical and Immunologic Outcomes in Food Allergen Immunotherapy by Route of Administration Curr Allergy Asthma Rep [Internet] Available from, 2015.

M. Vazquez-ortiz, M. Alvaro, M. Piquer, O. Dominguez, A. Machinena et al., Baseline specific IgE levels are useful to predict safety of oral immunotherapy in egg-allergic children, Clinical & Experimental Allergy, vol.59, issue.1, pp.130-171, 2014.
DOI : 10.1111/cea.12233

M. Vázquez-ortiz, M. Alvaro-lozano, L. Alsina, M. Garcia-paba, M. Piquer-gibert et al., Safety and predictors of adverse events during oral immunotherapy for milk allergy: severity of reaction at oral challenge, specific IgE and prick test, Clinical & Experimental Allergy, vol.127, issue.Suppl 1, pp.201392-102
DOI : 10.1111/cea.12012

A. Lucendo, A. Arias, and J. Tenias, Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol, pp.624-633, 2014.

G. Senna, M. Calderon, and M. Milani, for the treatment of grass pollen allergy, Expert Review of Clinical Immunology, vol.7, issue.1, pp.21-28, 2011.
DOI : 10.1586/eci.10.89

A. Kostadinova, L. Willemsen, L. Knippels, and J. Garssen, Immunotherapy - risk/benefit in food allergy. Pediatr Allergy Immunol, pp.633-677, 2013.

M. Marogna, I. Spadolini, A. Massolo, G. Canonica, and G. Passalacqua, Long-lasting effects of sublingual immunotherapy according to its duration: A??15-year prospective study, Journal of Allergy and Clinical Immunology, vol.126, issue.5, pp.969-75, 2010.
DOI : 10.1016/j.jaci.2010.08.030

D. Fleischer, A. Burks, B. Vickery, A. Scurlock, R. Wood et al., Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled Multicenter Trial (CoFAR), Journal of Allergy and Clinical Immunology, vol.129, issue.2, pp.119-146, 2013.
DOI : 10.1016/j.jaci.2011.12.739

S. Narisety, P. Frischmeyer-guerrerio, C. Keet, M. Gorelik, J. Schroeder et al., A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy, J Allergy Clin Immunol, 2015.

P. Holt, P. Sly, H. Sampson, P. Robinson, R. Loh et al., Prophylactic use of sublingual allergen immunotherapy in high-risk children: A??pilot study, Journal of Allergy and Clinical Immunology, vol.132, issue.4, pp.991-994, 2013.
DOI : 10.1016/j.jaci.2013.04.049

L. Tordesillas, R. Goswami, S. Benedé, G. Grishina, D. Dunkin et al., Skin exposure promotes a Th2-dependent sensitization to peanut allergens, Journal of Clinical Investigation, vol.124, issue.11, 2014.
DOI : 10.1172/JCI75660DS1

H. Brough, A. Simpson, K. Makinson, J. Hankinson, S. Brown et al., Peanut allergy: Effect of environmental peanut exposure in children with filaggrin loss-of-function mutations, Journal of Allergy and Clinical Immunology, vol.134, issue.4, pp.867-75, 2014.
DOI : 10.1016/j.jaci.2014.08.011

A. Fox, P. Sasieni, G. Du-toit, H. Syed, and G. Lack, Household peanut consumption as a risk factor for the development of peanut allergy, Journal of Allergy and Clinical Immunology, vol.123, issue.2, pp.417-440, 2009.
DOI : 10.1016/j.jaci.2008.12.014

V. Dioszeghy, L. Mondoulet, V. Dhelft, M. Ligouis, E. Puteaux et al., Epicutaneous Immunotherapy Results in Rapid Allergen Uptake by Dendritic Cells through Intact Skin and Downregulates the Allergen-Specific Response in Sensitized Mice, The Journal of Immunology, vol.186, issue.10, pp.5629-5666, 1950.
DOI : 10.4049/jimmunol.1003134

V. Dioszeghy, L. Mondoulet, V. Dhelft, M. Ligouis, E. Puteaux et al., The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice, Clinical & Experimental Allergy, vol.199, issue.6, pp.867-81, 2014.
DOI : 10.1111/cea.12312

C. Dupont, N. Kalach, P. Soulaines, S. Legoué-morillon, H. Piloquet et al., Cow's milk epicutaneous immunotherapy in children: A??pilot trial of safety, acceptability, and impact on allergic reactivity, Journal of Allergy and Clinical Immunology, vol.125, issue.5, pp.1165-1172, 2010.
DOI : 10.1016/j.jaci.2010.02.029

H. Sampson, W. Agbotounou, C. Thébault, R. Charles, L. Martin et al., Epicutaneous Immunotherapy (EPIT) Is Effective and Safe to Treat Peanut Allergy: A Multi-National Double-Blind Placebo-Controlled Randomized Phase IIb Trial, Journal of Allergy and Clinical Immunology, vol.135, issue.2, p.390, 2015.
DOI : 10.1016/j.jaci.2014.12.1901

H. Sampson, D. Leung, A. Burks, G. Lack, S. Bahna et al., A phase II, randomized, double???blind, parallel???group, placebo???controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy, Journal of Allergy and Clinical Immunology, vol.127, issue.5, pp.1309-1319, 2011.
DOI : 10.1016/j.jaci.2011.01.051

C. Yee and R. Rachid, The Heterogeneity of Oral Immunotherapy Clinical Trials: Implications and Future Directions. Curr Allergy Asthma Rep, Feb, vol.2716, issue.4, pp.1-19, 2016.

R. Wood, J. Kim, R. Lindblad, K. Nadeau, A. Henning et al., A randomized, doubleblind , placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy, J Allergy Clin Immunol [Internet], 2015.

O. Pagovich, B. Wang, M. Chiuchiolo, S. Kaminsky, D. Sondhi et al., Anti-hIgE gene therapy of peanut-induced anaphylaxis in a humanized murine model of peanut allergy, Journal of Allergy and Clinical Immunology, vol.138, issue.6, 2016.
DOI : 10.1016/j.jaci.2016.03.053

A. Wheeler, J. Marshall, and J. Ulrich, A Th1-Inducing Adjuvant, MPL^??, Enhances Antibody Profiles in Experimental Animals Suggesting It Has the Potential to Improve the Efficacy of Allergy Vaccines, International Archives of Allergy and Immunology, vol.126, issue.2, pp.135-144, 2001.
DOI : 10.1159/000049504

N. Mothes, M. Heinzkill, K. Drachenberg, W. Sperr, M. Krauth et al., Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.8, issue.9, 2003.
DOI : 10.1016/S0014-5793(99)01703-2

M. Crivellaro, G. Senna, A. Pappacoda, R. Vanzelli, B. Spacal et al., Safety of ultrashortterm sit with pollen allergoids adjuvanted by monophosphoryl lipid A: a prospective Italian survey, Eur Ann Allergy Clin Immunol, vol.43, issue.2, pp.58-60, 2011.

P. Creticos, J. Schroeder, R. Hamilton, S. Balcer-whaley, A. Khattignavong et al., Immunotherapy with a Ragweed???Toll-Like Receptor 9 Agonist Vaccine for Allergic Rhinitis, New England Journal of Medicine, vol.355, issue.14, pp.1445-55, 2006.
DOI : 10.1056/NEJMoa052916

D. Fonseca, P. Wowk, M. Paula, A. Gembre, M. Baruffi et al., Requirement of MyD88 and Fas pathways for the efficacy of allergen-free immunotherapy, Allergy, vol.32, issue.3, pp.275-84, 2015.
DOI : 10.1111/all.12555

P. Haldar, C. Brightling, B. Hargadon, S. Gupta, W. Monteiro et al., Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma, New England Journal of Medicine, vol.360, issue.10, pp.973-84, 2009.
DOI : 10.1056/NEJMoa0808991

P. Nair, M. Pizzichini, M. Kjarsgaard, M. Inman, A. Efthimiadis et al., Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia, New England Journal of Medicine, vol.360, issue.10, pp.985-93, 2009.
DOI : 10.1056/NEJMoa0805435

A. Straumann, S. Conus, P. Grzonka, H. Kita, G. Kephart et al., Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial, Gut, vol.59, issue.01, pp.21-30, 2010.
DOI : 10.1136/gut.2009.178558

A. Parulekar, J. Boomer, B. Patterson, H. Yin-declue, C. Deppong et al., A Randomized Controlled Trial to Evaluate Inhibition of T-Cell Costimulation in Allergen-induced Airway Inflammation, American Journal of Respiratory and Critical Care Medicine, vol.187, issue.5, pp.494-501, 2013.
DOI : 10.1164/rccm.201207-1205OC

D. Wesemann and C. Nagler, The Microbiome, Timing, and Barrier Function in the Context of Allergic Disease, Immunity, vol.44, issue.4, pp.728-766
DOI : 10.1016/j.immuni.2016.02.002

J. Cahenzli, Y. Köller, M. Wyss, M. Geuking, and K. Mccoy, Intestinal microbial diversity during earlylife colonization shapes long-term IgE levels. Cell Host Microbe, Nov, vol.1314, issue.5, pp.559-70, 2013.
DOI : 10.1016/j.chom.2013.10.004
URL : http://doi.org/10.1016/j.chom.2013.10.004

D. Hill, M. Siracusa, M. Abt, B. Kim, D. Kobuley et al., Commensal bacteria???derived signals regulate basophil hematopoiesis and allergic inflammation, Nature Medicine, vol.180, issue.4, 2012.
DOI : 10.1016/j.jaci.2011.06.045
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321082

G. Prioult and C. Nagler-anderson, Mucosal immunity and allergic responses: lack of regulation and/or lack of microbial stimulation?, Immunological Reviews, vol.173, issue.1, pp.204-222, 2005.
DOI : 10.1002/eji.200324340

C. Ai, Q. Zhang, J. Ding, G. Wang, X. Liu et al., Mucosal delivery of allergen peptides expressed by Lactococcus lactis inhibit allergic responses in a BALB/c mouse model, Applied Microbiology and Biotechnology, vol.203, issue.3, pp.1915-1939, 2016.
DOI : 10.1007/s00253-015-7187-8

C. Frossard, L. Steidler, and P. Eigenmann, Oral administration of an IL-10???secreting Lactococcus lactis strain prevents food-induced IgE sensitization, Journal of Allergy and Clinical Immunology, vol.119, issue.4, 2007.
DOI : 10.1016/j.jaci.2006.12.615

J. Kearley, D. Robinson, and C. Lloyd, CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling, Journal of Allergy and Clinical Immunology, vol.122, issue.3, 2008.
DOI : 10.1016/j.jaci.2008.05.048
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389733

J. Kearley, J. Barker, D. Robinson, and C. Lloyd, regulatory T cells is interleukin 10 dependent, The Journal of Experimental Medicine, vol.64, issue.11, pp.1539-1586, 2005.
DOI : 10.4049/jimmunol.166.3.2033

D. Klatzmann and A. Abbas, The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases, Nature Reviews Immunology, vol.134, issue.5, pp.283-94, 2015.
DOI : 10.1016/S0140-6736(00)02799-9

R. Royal, S. Steinberg, R. Krouse, G. Heywood, D. White et al., Correlates of response to IL-2 therapy in patients treated for metastatic renal cancer and melanoma, Cancer J Sci Am, vol.2, issue.2, pp.91-99, 1996.

S. Nizar, J. Copier, B. Meyer, M. Bodman-smith, C. Galustian et al., T-regulatory cell modulation: the future of cancer immunotherapy? Br J Cancer, pp.1697-703, 2009.

Y. Grinberg-bleyer, A. Baeyens, S. You, R. Elhage, G. Fourcade et al., IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells, The Journal of Experimental Medicine, vol.207, issue.9, pp.1871-1879, 2010.
DOI : 10.1038/ni.1774

O. Boyman, C. Surh, and J. Sprent, Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease, Expert Opinion on Biological Therapy, vol.9, issue.12, pp.1323-1354, 2006.
DOI : 10.1126/science.288.5466.675

S. Lee, M. Cho, H. Oh, J. Ryu, M. Park et al., Interleukin-2/anti-interleukin-2 monoclonal antibody immune complex suppresses collagen-induced arthritis in mice by fortifying interleukin-2/STAT5 signalling pathways, Immunology, vol.178, issue.4, pp.305-321, 2012.
DOI : 10.1111/imm.12008

T. Dinh, T. Kyaw, P. Kanellakis, K. To, P. Tipping et al., Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis. Circulation, pp.1256-66, 2012.

R. Liu, Q. Zhou, L. Cava, A. Campagnolo, D. Van-kaer et al., Expansion of regulatory T cells via IL-2/anti-IL-2 mAb complexes suppresses experimental myasthenia, European Journal of Immunology, vol.74, issue.6, 2010.
DOI : 10.1002/eji.200939792

J. Hao, D. Campagnolo, R. Liu, W. Piao, S. Shi et al., Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation, Annals of Neurology, vol.206, issue.4, pp.721-755, 2011.
DOI : 10.1002/ana.22339
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082615

S. Villalta, W. Rosenthal, L. Martinez, A. Kaur, T. Sparwasser et al., Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy, Science Translational Medicine, vol.6, issue.258, pp.258-142, 2014.
DOI : 10.1126/scitranslmed.3009925

K. Kasahara, N. Sasaki, T. Yamashita, T. Kita, K. Yodoi et al., CD3 Antibody and IL-2 Complex Combination Therapy Inhibits Atherosclerosis by Augmenting a Regulatory Immune Response, Journal of the American Heart Association, vol.3, issue.2, p.719, 2014.
DOI : 10.1161/JAHA.113.000719

S. Brandenburg, T. Takahashi, M. De-la-rosa, M. Janke, G. Karsten et al., IL-2 induces in vivo suppression by CD4+CD25+Foxp3+ regulatory T cells, European Journal of Immunology, vol.160, issue.6, pp.1643-53, 2008.
DOI : 10.1002/eji.200737791

T. Dietrich, T. Hucko, C. Schneemann, M. Neumann, A. Menrad et al., Local delivery of IL-2 reduces atherosclerosis via expansion of regulatory T cells, Atherosclerosis, vol.220, issue.2, 2012.
DOI : 10.1016/j.atherosclerosis.2011.09.050

D. 'alessio, F. Tsushima, K. Aggarwal, N. West, E. Willett et al., CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury, J Clin Invest, vol.119, issue.10, pp.2898-913, 2009.

A. Hartemann, G. Bensimon, C. Payan, S. Jacqueminet, O. Bourron et al., Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial, The Lancet Diabetes & Endocrinology, vol.1, issue.4, pp.295-305, 2013.
DOI : 10.1016/S2213-8587(13)70113-X

J. Koreth, K. Matsuoka, H. Kim, S. Mcdonough, B. Bindra et al., Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease, New England Journal of Medicine, vol.365, issue.22, pp.2055-66, 2011.
DOI : 10.1056/NEJMoa1108188

V. Spee-mayer, C. Siegert, E. Abdirama, D. Rose, A. Klaus et al., Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus, Annals of the Rheumatic Diseases, vol.74, issue.7, 2015.
DOI : 10.1136/annrheumdis-2015-207776

M. Hordinsky and D. Kaplan, Low-Dose Interleukin 2 to Reverse Alopecia Areata, JAMA Dermatology, vol.150, issue.7, pp.696-703, 2014.
DOI : 10.1001/jamadermatol.2014.510

A. Kosmaczewska, Low-Dose Interleukin-2 Therapy: A Driver of an Imbalance between Immune Tolerance and Autoimmunity, International Journal of Molecular Sciences, vol.15, issue.10, pp.18574-92, 2014.
DOI : 10.3390/ijms151018574

K. Cook, H. Kline, and J. Whitmire, NK cells inhibit humoral immunity by reducing the abundance of CD4+ T follicular helper cells during a chronic virus infection, Journal of Leukocyte Biology, vol.98, issue.2, 2015.
DOI : 10.1189/jlb.4HI1214-594R

Q. Tang, K. Henriksen, M. Bi, E. Finger, G. Szot et al., In Vitro???expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes, The Journal of Experimental Medicine, vol.161, issue.11, pp.1455-65, 2004.
DOI : 10.1016/S1521-6616(02)00017-7

G. Churlaud, V. Jimenez, J. Ruberte, A. Zin, M. Fourcade et al., Sustained stimulation and expansion of Tregs by IL2 control autoimmunity without impairing immune responses to infection, vaccination and cancer, Clinical Immunology, vol.151, issue.2, 2014.
DOI : 10.1016/j.clim.2014.02.003